Last 12 months
Inside the activity.
0 purchase rows · 9 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 5 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 13, 2026 Filed Mar 17, 2026 21:59 UTC |
Richard Christian MDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 74,700 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-029639 · tm269084-6_4seq1.xml · derivative · entry 3 Richard Christian M · CIK 0001645967 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 74,700 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: 74,700 Restricted Stock Units ("RSUs") previously granted by Cypherpunk Technologies Inc. (the "Company") to the reporting person on November 11, 2025 pursuant to the Company's 2022 Equity Incentive Plan for no consideration (the "November 2025 RSUs") were settled on March 13, 2026 on a 1 for 1 basis for shares of the Company's common stock, par value $0.001 per share ("Common Stock"). F3 · derivative.exercise_date: The November 2025 RSUs vested at issuance on their grant date. F3 · derivative.expiration_date: The November 2025 RSUs vested at issuance on their grant date. Read SEC document |
| March 13, 2026 Filed Mar 17, 2026 21:59 UTC |
Richard Christian MDirector
|
Exercise / conversionCommon Stock | 94,050 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-029639 · tm269084-6_4seq1.xml · nonDerivative · entry 2 Richard Christian M · CIK 0001645967 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 168,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: 94,050 RSUs previously granted by the Company to the reporting person on December 23, 2025 pursuant to the Company's 2025 Equity Incentive Plan for no consideration (the "December 2025 RSUs") were settled on March 13, 2026 on a 1 for 1 basis for shares of Common Stock. F2 · price: 94,050 RSUs previously granted by the Company to the reporting person on December 23, 2025 pursuant to the Company's 2025 Equity Incentive Plan for no consideration (the "December 2025 RSUs") were settled on March 13, 2026 on a 1 for 1 basis for shares of Common Stock. Read SEC document |
| March 13, 2026 Filed Mar 17, 2026 21:59 UTC |
Richard Christian MDirector
|
Exercise / conversionCommon Stock | 74,700 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-029639 · tm269084-6_4seq1.xml · nonDerivative · entry 1 Richard Christian M · CIK 0001645967 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,700 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: 74,700 Restricted Stock Units ("RSUs") previously granted by Cypherpunk Technologies Inc. (the "Company") to the reporting person on November 11, 2025 pursuant to the Company's 2022 Equity Incentive Plan for no consideration (the "November 2025 RSUs") were settled on March 13, 2026 on a 1 for 1 basis for shares of the Company's common stock, par value $0.001 per share ("Common Stock"). F1 · price: 74,700 Restricted Stock Units ("RSUs") previously granted by Cypherpunk Technologies Inc. (the "Company") to the reporting person on November 11, 2025 pursuant to the Company's 2022 Equity Incentive Plan for no consideration (the "November 2025 RSUs") were settled on March 13, 2026 on a 1 for 1 basis for shares of the Company's common stock, par value $0.001 per share ("Common Stock"). Read SEC document |
| March 13, 2026 Filed Mar 17, 2026 21:58 UTC |
Martin Patricia A.Director
|
Exercise / conversionRestricted Stock Units · Derivative | 94,050 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-029637 · tm269084-4_4seq1.xml · derivative · entry 4 Martin Patricia A. · CIK 0001916764 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 94,050 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: 94,050 RSUs previously granted by the Company to the reporting person on December 23, 2025 pursuant to the Company's 2025 Equity Incentive Plan for no consideration (the "December 2025 RSUs") were settled on March 13, 2026 on a 1 for 1 basis for shares of Common Stock. F4 · derivative.exercise_date: The December 2025 RSUs vested at issuance on their grant date. F4 · derivative.expiration_date: The December 2025 RSUs vested at issuance on their grant date. Read SEC document |
| March 13, 2026 Filed Mar 17, 2026 21:58 UTC |
Martin Patricia A.Director
|
Exercise / conversionRestricted Stock Units · Derivative | 74,700 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-029637 · tm269084-4_4seq1.xml · derivative · entry 3 Martin Patricia A. · CIK 0001916764 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 74,700 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: 74,700 Restricted Stock Units ("RSUs") previously granted by Cypherpunk Technologies Inc. (the "Company") to the reporting person on November 11, 2025 pursuant to the Company's 2022 Equity Incentive Plan for no consideration (the "November 2025 RSUs") were settled on March 13, 2026 on a 1 for 1 basis for shares of the Company's common stock, par value $0.001 per share ("Common Stock"). F3 · derivative.exercise_date: The November 2025 RSUs vested at issuance on their grant date. F3 · derivative.expiration_date: The November 2025 RSUs vested at issuance on their grant date. Read SEC document |
| March 13, 2026 Filed Mar 17, 2026 21:58 UTC |
Martin Patricia A.Director
|
Exercise / conversionCommon Stock | 94,050 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-029637 · tm269084-4_4seq1.xml · nonDerivative · entry 2 Martin Patricia A. · CIK 0001916764 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 168,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: 94,050 RSUs previously granted by the Company to the reporting person on December 23, 2025 pursuant to the Company's 2025 Equity Incentive Plan for no consideration (the "December 2025 RSUs") were settled on March 13, 2026 on a 1 for 1 basis for shares of Common Stock. F2 · price: 94,050 RSUs previously granted by the Company to the reporting person on December 23, 2025 pursuant to the Company's 2025 Equity Incentive Plan for no consideration (the "December 2025 RSUs") were settled on March 13, 2026 on a 1 for 1 basis for shares of Common Stock. Read SEC document |
| March 13, 2026 Filed Mar 17, 2026 21:58 UTC |
Martin Patricia A.Director
|
Exercise / conversionCommon Stock | 74,700 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-029637 · tm269084-4_4seq1.xml · nonDerivative · entry 1 Martin Patricia A. · CIK 0001916764 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,700 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: 74,700 Restricted Stock Units ("RSUs") previously granted by Cypherpunk Technologies Inc. (the "Company") to the reporting person on November 11, 2025 pursuant to the Company's 2022 Equity Incentive Plan for no consideration (the "November 2025 RSUs") were settled on March 13, 2026 on a 1 for 1 basis for shares of the Company's common stock, par value $0.001 per share ("Common Stock"). F1 · price: 74,700 Restricted Stock Units ("RSUs") previously granted by Cypherpunk Technologies Inc. (the "Company") to the reporting person on November 11, 2025 pursuant to the Company's 2022 Equity Incentive Plan for no consideration (the "November 2025 RSUs") were settled on March 13, 2026 on a 1 for 1 basis for shares of the Company's common stock, par value $0.001 per share ("Common Stock"). Read SEC document |
| March 13, 2026 Filed Mar 17, 2026 21:57 UTC |
Schilsky RichardDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 94,050 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-029635 · tm269084-3_4seq1.xml · derivative · entry 4 Schilsky Richard · CIK 0001945662 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 94,050 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: 94,050 RSUs previously granted by the Company to the reporting person on December 23, 2025 pursuant to the Company's 2025 Equity Incentive Plan for no consideration (the "December 2025 RSUs") were settled on March 13, 2026 on a 1 for 1 basis for shares of Common Stock. F4 · derivative.exercise_date: The December 2025 RSUs vested at issuance on their grant date. F4 · derivative.expiration_date: The December 2025 RSUs vested at issuance on their grant date. Read SEC document |
| March 13, 2026 Filed Mar 17, 2026 21:57 UTC |
Schilsky RichardDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 74,700 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-029635 · tm269084-3_4seq1.xml · derivative · entry 3 Schilsky Richard · CIK 0001945662 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 74,700 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: 74,700 Restricted Stock Units ("RSUs") previously granted by Cypherpunk Technologies Inc. (the "Company") to the reporting person on November 11, 2025 pursuant to the Company's 2022 Equity Incentive Plan for no consideration (the "November 2025 RSUs") were settled on March 13, 2026 on a 1 for 1 basis for shares of the Company's common stock, par value $0.001 per share ("Common Stock"). F3 · derivative.exercise_date: The November 2025 RSUs vested at issuance on their grant date. F3 · derivative.expiration_date: The November 2025 RSUs vested at issuance on their grant date. Read SEC document |
| March 13, 2026 Filed Mar 17, 2026 21:57 UTC |
Schilsky RichardDirector
|
Exercise / conversionCommon Stock | 94,050 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-029635 · tm269084-3_4seq1.xml · nonDerivative · entry 2 Schilsky Richard · CIK 0001945662 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 168,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: 94,050 RSUs previously granted by the Company to the reporting person on December 23, 2025 pursuant to the Company's 2025 Equity Incentive Plan for no consideration (the "December 2025 RSUs") were settled on March 13, 2026 on a 1 for 1 basis for shares of Common Stock. F2 · price: 94,050 RSUs previously granted by the Company to the reporting person on December 23, 2025 pursuant to the Company's 2025 Equity Incentive Plan for no consideration (the "December 2025 RSUs") were settled on March 13, 2026 on a 1 for 1 basis for shares of Common Stock. Read SEC document |
| March 13, 2026 Filed Mar 17, 2026 21:57 UTC |
Schilsky RichardDirector
|
Exercise / conversionCommon Stock | 74,700 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-029635 · tm269084-3_4seq1.xml · nonDerivative · entry 1 Schilsky Richard · CIK 0001945662 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,700 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: 74,700 Restricted Stock Units ("RSUs") previously granted by Cypherpunk Technologies Inc. (the "Company") to the reporting person on November 11, 2025 pursuant to the Company's 2022 Equity Incentive Plan for no consideration (the "November 2025 RSUs") were settled on March 13, 2026 on a 1 for 1 basis for shares of the Company's common stock, par value $0.001 per share ("Common Stock"). F1 · price: 74,700 Restricted Stock Units ("RSUs") previously granted by Cypherpunk Technologies Inc. (the "Company") to the reporting person on November 11, 2025 pursuant to the Company's 2022 Equity Incentive Plan for no consideration (the "November 2025 RSUs") were settled on March 13, 2026 on a 1 for 1 basis for shares of the Company's common stock, par value $0.001 per share ("Common Stock"). Read SEC document |
| December 26, 2025 Filed Dec 30, 2025 21:33 UTC |
Dietz Thomas JohnDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 83,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-125256 · tm2534450-5_4seq1.xml · derivative · entry 3 Dietz Thomas John · CIK 0001574218 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 83,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Represents RSUs to be settled on a 1 for 1 basis for shares of Company Common Stock. The November 2025 RSUs were awarded pursuant to the Company's 2022 Equity Incentive Plan for no consideration. F1 · kind: 83,000 Restricted Stock Units ("RSUs") previously granted by Cypherpunk Technologies Inc. (the "Company") to the reporting person on November 11, 2025 (the "November 2025 RSUs") were settled on December 26, 2025 on a net issue basis such that, of the 83,000 shares of the Company's common stock, par value $0.001 per share ("Common Stock") underlying the November 2025 RSUs, the Company issued to the reporting person on such settlement date only 48,000 of such shares, and the Company withheld on such settlement date the remaining 35,000 of such shares in order to satisfy tax withholding obligations in connection with the settlement of the November 2025 RSUs. None of such 35,000 shares of Common Stock so withheld by the Company constituted sales of such shares by the reporting person. F3 · derivative.exercise_date: The November 2025 RSUs vested at issuance on their grant date. On December 26, 2025, the Compensation Committee of the Board of Directors took action to permit the early settlement of the November 2025 RSUs on a net issue basis as further described in footnote (1) above. F3 · derivative.expiration_date: The November 2025 RSUs vested at issuance on their grant date. On December 26, 2025, the Compensation Committee of the Board of Directors took action to permit the early settlement of the November 2025 RSUs on a net issue basis as further described in footnote (1) above. Read SEC document |
| December 26, 2025 Filed Dec 30, 2025 21:33 UTC |
Dietz Thomas JohnDirector
|
Tax withholdingCommon Stock | 35,000 | $1.20 | $42,000.00 |
DisclosureSEC source: 0001104659-25-125256 · tm2534450-5_4seq1.xml · nonDerivative · entry 2 Dietz Thomas John · CIK 0001574218 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,000 F1 · kind: 83,000 Restricted Stock Units ("RSUs") previously granted by Cypherpunk Technologies Inc. (the "Company") to the reporting person on November 11, 2025 (the "November 2025 RSUs") were settled on December 26, 2025 on a net issue basis such that, of the 83,000 shares of the Company's common stock, par value $0.001 per share ("Common Stock") underlying the November 2025 RSUs, the Company issued to the reporting person on such settlement date only 48,000 of such shares, and the Company withheld on such settlement date the remaining 35,000 of such shares in order to satisfy tax withholding obligations in connection with the settlement of the November 2025 RSUs. None of such 35,000 shares of Common Stock so withheld by the Company constituted sales of such shares by the reporting person. Read SEC document |
| December 26, 2025 Filed Dec 30, 2025 21:33 UTC |
Dietz Thomas JohnDirector
|
Exercise / conversionCommon Stock | 83,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-25-125256 · tm2534450-5_4seq1.xml · nonDerivative · entry 1 Dietz Thomas John · CIK 0001574218 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: 83,000 Restricted Stock Units ("RSUs") previously granted by Cypherpunk Technologies Inc. (the "Company") to the reporting person on November 11, 2025 (the "November 2025 RSUs") were settled on December 26, 2025 on a net issue basis such that, of the 83,000 shares of the Company's common stock, par value $0.001 per share ("Common Stock") underlying the November 2025 RSUs, the Company issued to the reporting person on such settlement date only 48,000 of such shares, and the Company withheld on such settlement date the remaining 35,000 of such shares in order to satisfy tax withholding obligations in connection with the settlement of the November 2025 RSUs. None of such 35,000 shares of Common Stock so withheld by the Company constituted sales of such shares by the reporting person. F2 · price: Represents RSUs to be settled on a 1 for 1 basis for shares of Company Common Stock. The November 2025 RSUs were awarded pursuant to the Company's 2022 Equity Incentive Plan for no consideration. Read SEC document |
| December 23, 2025 Filed Dec 30, 2025 16:34 UTC |
CAVANAUGH JAMES HDirector
|
GrantRestricted Stock Units · Derivative | 94,050 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-125258 · tm2534450-6_4seq1.xml · derivative · entry 1 CAVANAUGH JAMES H · CIK 0001013473 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,050 Underlying: Common Stock · 94,050 shares Expires not disclosed F1 · derivative.exercise_price: Represents restricted stock units ("RSUs") to be settled on a 1 for 1 basis for shares of Cypherpunk Technologies Inc. ("Company") common stock, par value $0.001 per share ("Common Stock"). The RSUs were awarded pursuant to the Company's 2025 Equity Incentive Plan for no consideration. F2 · derivative.exercise_date: The RSUs vested at issuance on December 23, 2025 (the "Grant Date"). Subject to the terms of the RSU award and applicable tax withholdings, the Company shall settle the RSUs for Common Stock as soon as practicable following the earlier to occur of (i) the fifth (5th) business day after the date the reporting person ceases for any reason to be a member of the Company's Board of Directors or (ii) the date of the first annual meeting of stockholders of the Company that occurs following the Grant Date. F2 · derivative.expiration_date: The RSUs vested at issuance on December 23, 2025 (the "Grant Date"). Subject to the terms of the RSU award and applicable tax withholdings, the Company shall settle the RSUs for Common Stock as soon as practicable following the earlier to occur of (i) the fifth (5th) business day after the date the reporting person ceases for any reason to be a member of the Company's Board of Directors or (ii) the date of the first annual meeting of stockholders of the Company that occurs following the Grant Date. Read SEC document |
| December 23, 2025 Filed Dec 30, 2025 21:41 UTC |
LI WILLIAMDirector
|
GrantRestricted Stock Units · Derivative | 94,050 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-125270 · tm2534450-12_4seq1.xml · derivative · entry 1 LI WILLIAM · CIK 0001273806 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,050 Underlying: Common Stock · 94,050 shares Expires not disclosed F1 · derivative.exercise_price: Represents restricted stock units ("RSUs") to be settled on a 1 for 1 basis for shares of Cypherpunk Technologies Inc. ("Company") common stock, par value $0.001 per share ("Common Stock"). The RSUs were awarded pursuant to the Company's 2025 Equity Incentive Plan for no consideration. F2 · derivative.exercise_date: The RSUs vested at issuance on December 23, 2025 (the "Grant Date"). Subject to the terms of the RSU award and applicable tax withholdings, the Company shall settle the RSUs for Common Stock as soon as practicable following the earlier to occur of (i) the fifth (5th) business day after the date the reporting person ceases for any reason to be a member of the Company's Board of Directors or (ii) the date of the first annual meeting of stockholders of the Company that occurs following the Grant Date. F2 · derivative.expiration_date: The RSUs vested at issuance on December 23, 2025 (the "Grant Date"). Subject to the terms of the RSU award and applicable tax withholdings, the Company shall settle the RSUs for Common Stock as soon as practicable following the earlier to occur of (i) the fifth (5th) business day after the date the reporting person ceases for any reason to be a member of the Company's Board of Directors or (ii) the date of the first annual meeting of stockholders of the Company that occurs following the Grant Date. Read SEC document |
| December 23, 2025 Filed Dec 30, 2025 21:30 UTC |
ONSI DOUGLAS EDirector · CEO,CFO,Pres.,GC,Treas.&Sec.
|
GrantRestricted Stock Units · Derivative | 2,600,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-125251 · tm2534450-2_4seq1.xml · derivative · entry 3 ONSI DOUGLAS E · CIK 0001270185 · Director · CEO,CFO,Pres.,GC,Treas.&Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,600,000 Underlying: Common Stock · 2,600,000 shares Expires not disclosed F4 · derivative.exercise_price: Represents restricted stock units ("RSUs") to be settled on a 1 for 1 basis for shares of Company Common Stock. The RSUs were awarded pursuant to the Company's 2025 Equity Incentive Plan for no consideration. F5 · derivative.exercise_date: The RSUs will vest at (i) 12/36th on October 8, 2026 and (ii) 1/36th on the eighth (8th) day of each month thereafter (each, a "Vesting Date"), subject to the reporting person's continued service with the Company. Subject to the terms of the RSU award and applicable tax withholdings, the Company shall settle vested RSUs for Common Stock on the earliest to occur of (i) the first payroll period on or after the date the reporting person's employment with or service to the Company ceases, (ii) the first payroll period on or after the eighth (8th) day of the calendar month of June following any such Vesting Date applicable to such vested RSU or (iii) the first payroll period on or after the eighth (8th) day of the month of December following any such Vesting Date. F5 · derivative.expiration_date: The RSUs will vest at (i) 12/36th on October 8, 2026 and (ii) 1/36th on the eighth (8th) day of each month thereafter (each, a "Vesting Date"), subject to the reporting person's continued service with the Company. Subject to the terms of the RSU award and applicable tax withholdings, the Company shall settle vested RSUs for Common Stock on the earliest to occur of (i) the first payroll period on or after the date the reporting person's employment with or service to the Company ceases, (ii) the first payroll period on or after the eighth (8th) day of the calendar month of June following any such Vesting Date applicable to such vested RSU or (iii) the first payroll period on or after the eighth (8th) day of the month of December following any such Vesting Date. Read SEC document |
| December 23, 2025 Filed Dec 30, 2025 21:30 UTC |
ONSI DOUGLAS EDirector · CEO,CFO,Pres.,GC,Treas.&Sec.
|
OtherCommon Stock | 712 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-125251 · tm2534450-2_4seq1.xml · nonDerivative · entry 2 ONSI DOUGLAS E · CIK 0001270185 · Director · CEO,CFO,Pres.,GC,Treas.&Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,858 F1 · kind: Pro rata distribution from Nine Capital Partners, LLC ("Nine Capital Partners") of an aggregate of 2,136 shares of Cypherpunk Technologies Inc. ("Company") common stock, par value $0.001 per share ("Common Stock"), with 712 shares of Common Stock distributed to each of Messrs. Christopher K. Mirabelli, Douglas E. Onsi and Augustine Lawlor, respectively. Messrs. Mirabelli, Onsi and Lawlor are the Managing Members of Nine Capital Partners and as such, beneficially own and share voting and dispositive power with respect to all of the securities owned by Nine Capital Partners, LLC. F3 · shares: Reflects a de minimis adjustment due to rounding. F1 · price: Pro rata distribution from Nine Capital Partners, LLC ("Nine Capital Partners") of an aggregate of 2,136 shares of Cypherpunk Technologies Inc. ("Company") common stock, par value $0.001 per share ("Common Stock"), with 712 shares of Common Stock distributed to each of Messrs. Christopher K. Mirabelli, Douglas E. Onsi and Augustine Lawlor, respectively. Messrs. Mirabelli, Onsi and Lawlor are the Managing Members of Nine Capital Partners and as such, beneficially own and share voting and dispositive power with respect to all of the securities owned by Nine Capital Partners, LLC. Read SEC document |
| December 23, 2025 Filed Dec 30, 2025 21:30 UTC |
ONSI DOUGLAS EDirector · CEO,CFO,Pres.,GC,Treas.&Sec.
|
OtherCommon Stock | 2,136 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-125251 · tm2534450-2_4seq1.xml · nonDerivative · entry 1 ONSI DOUGLAS E · CIK 0001270185 · Director · CEO,CFO,Pres.,GC,Treas.&Sec. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 0 F1 · kind: Pro rata distribution from Nine Capital Partners, LLC ("Nine Capital Partners") of an aggregate of 2,136 shares of Cypherpunk Technologies Inc. ("Company") common stock, par value $0.001 per share ("Common Stock"), with 712 shares of Common Stock distributed to each of Messrs. Christopher K. Mirabelli, Douglas E. Onsi and Augustine Lawlor, respectively. Messrs. Mirabelli, Onsi and Lawlor are the Managing Members of Nine Capital Partners and as such, beneficially own and share voting and dispositive power with respect to all of the securities owned by Nine Capital Partners, LLC. F1 · shares: Pro rata distribution from Nine Capital Partners, LLC ("Nine Capital Partners") of an aggregate of 2,136 shares of Cypherpunk Technologies Inc. ("Company") common stock, par value $0.001 per share ("Common Stock"), with 712 shares of Common Stock distributed to each of Messrs. Christopher K. Mirabelli, Douglas E. Onsi and Augustine Lawlor, respectively. Messrs. Mirabelli, Onsi and Lawlor are the Managing Members of Nine Capital Partners and as such, beneficially own and share voting and dispositive power with respect to all of the securities owned by Nine Capital Partners, LLC. F1 · price: Pro rata distribution from Nine Capital Partners, LLC ("Nine Capital Partners") of an aggregate of 2,136 shares of Cypherpunk Technologies Inc. ("Company") common stock, par value $0.001 per share ("Common Stock"), with 712 shares of Common Stock distributed to each of Messrs. Christopher K. Mirabelli, Douglas E. Onsi and Augustine Lawlor, respectively. Messrs. Mirabelli, Onsi and Lawlor are the Managing Members of Nine Capital Partners and as such, beneficially own and share voting and dispositive power with respect to all of the securities owned by Nine Capital Partners, LLC. F1 · balance_after: Pro rata distribution from Nine Capital Partners, LLC ("Nine Capital Partners") of an aggregate of 2,136 shares of Cypherpunk Technologies Inc. ("Company") common stock, par value $0.001 per share ("Common Stock"), with 712 shares of Common Stock distributed to each of Messrs. Christopher K. Mirabelli, Douglas E. Onsi and Augustine Lawlor, respectively. Messrs. Mirabelli, Onsi and Lawlor are the Managing Members of Nine Capital Partners and as such, beneficially own and share voting and dispositive power with respect to all of the securities owned by Nine Capital Partners, LLC. F1 · ownership.nature: Pro rata distribution from Nine Capital Partners, LLC ("Nine Capital Partners") of an aggregate of 2,136 shares of Cypherpunk Technologies Inc. ("Company") common stock, par value $0.001 per share ("Common Stock"), with 712 shares of Common Stock distributed to each of Messrs. Christopher K. Mirabelli, Douglas E. Onsi and Augustine Lawlor, respectively. Messrs. Mirabelli, Onsi and Lawlor are the Managing Members of Nine Capital Partners and as such, beneficially own and share voting and dispositive power with respect to all of the securities owned by Nine Capital Partners, LLC. F2 · ownership.nature: The reporting person disclaims beneficial ownership of these shares except to the extent of his proportionate pecuniary interest therein. Read SEC document |
| December 23, 2025 Filed Dec 30, 2025 16:31 UTC |
Mirabelli ChristopherDirector
|
GrantRestricted Stock Units · Derivative | 94,050 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-125252 · tm2534450-3_4seq1.xml · derivative · entry 3 Mirabelli Christopher · CIK 0001262326 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,050 Underlying: Common Stock · 94,050 shares Expires not disclosed F4 · derivative.exercise_price: Represents restricted stock units ("RSUs") to be settled on a 1 for 1 basis for shares of Company Common Stock. The RSUs were awarded pursuant to the Company's 2025 Equity Incentive Plan for no consideration. F5 · derivative.exercise_date: The RSUs vested at issuance on December 23, 2025 (the "Grant Date"). Subject to the terms of the RSU award and applicable tax withholdings, the Company shall settle the RSUs for Common Stock as soon as practicable following the earlier to occur of (i) the fifth (5th) business day after the date the reporting person ceases for any reason to be a member of the Company's Board of Directors or (ii) the date of the first annual meeting of stockholders of the Company that occurs following the Grant Date. F5 · derivative.expiration_date: The RSUs vested at issuance on December 23, 2025 (the "Grant Date"). Subject to the terms of the RSU award and applicable tax withholdings, the Company shall settle the RSUs for Common Stock as soon as practicable following the earlier to occur of (i) the fifth (5th) business day after the date the reporting person ceases for any reason to be a member of the Company's Board of Directors or (ii) the date of the first annual meeting of stockholders of the Company that occurs following the Grant Date. Read SEC document |
| December 23, 2025 Filed Dec 30, 2025 16:31 UTC |
Mirabelli ChristopherDirector
|
OtherCommon Stock | 712 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-125252 · tm2534450-3_4seq1.xml · nonDerivative · entry 2 Mirabelli Christopher · CIK 0001262326 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,626 F1 · kind: Pro rata distribution from Nine Capital Partners, LLC ("Nine Capital Partners") of an aggregate of 2,136 shares of Cypherpunk Technologies Inc. ("Company") common stock, par value $0.001 per share ("Common Stock"), with 712 shares of Common Stock distributed to each of Messrs. Christopher K. Mirabelli, Douglas E. Onsi and Augustine Lawlor, respectively. Messrs. Mirabelli, Onsi and Lawlor are the Managing Members of Nine Capital Partners and as such, beneficially own and share voting and dispositive power with respect to all of the securities owned by Nine Capital Partners, LLC. F3 · shares: Reflects a de minimis adjustment due to rounding. F1 · price: Pro rata distribution from Nine Capital Partners, LLC ("Nine Capital Partners") of an aggregate of 2,136 shares of Cypherpunk Technologies Inc. ("Company") common stock, par value $0.001 per share ("Common Stock"), with 712 shares of Common Stock distributed to each of Messrs. Christopher K. Mirabelli, Douglas E. Onsi and Augustine Lawlor, respectively. Messrs. Mirabelli, Onsi and Lawlor are the Managing Members of Nine Capital Partners and as such, beneficially own and share voting and dispositive power with respect to all of the securities owned by Nine Capital Partners, LLC. Read SEC document |
| December 23, 2025 Filed Dec 30, 2025 16:31 UTC |
Mirabelli ChristopherDirector
|
OtherCommon Stock | 2,136 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-125252 · tm2534450-3_4seq1.xml · nonDerivative · entry 1 Mirabelli Christopher · CIK 0001262326 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 0 F1 · kind: Pro rata distribution from Nine Capital Partners, LLC ("Nine Capital Partners") of an aggregate of 2,136 shares of Cypherpunk Technologies Inc. ("Company") common stock, par value $0.001 per share ("Common Stock"), with 712 shares of Common Stock distributed to each of Messrs. Christopher K. Mirabelli, Douglas E. Onsi and Augustine Lawlor, respectively. Messrs. Mirabelli, Onsi and Lawlor are the Managing Members of Nine Capital Partners and as such, beneficially own and share voting and dispositive power with respect to all of the securities owned by Nine Capital Partners, LLC. F1 · shares: Pro rata distribution from Nine Capital Partners, LLC ("Nine Capital Partners") of an aggregate of 2,136 shares of Cypherpunk Technologies Inc. ("Company") common stock, par value $0.001 per share ("Common Stock"), with 712 shares of Common Stock distributed to each of Messrs. Christopher K. Mirabelli, Douglas E. Onsi and Augustine Lawlor, respectively. Messrs. Mirabelli, Onsi and Lawlor are the Managing Members of Nine Capital Partners and as such, beneficially own and share voting and dispositive power with respect to all of the securities owned by Nine Capital Partners, LLC. F1 · price: Pro rata distribution from Nine Capital Partners, LLC ("Nine Capital Partners") of an aggregate of 2,136 shares of Cypherpunk Technologies Inc. ("Company") common stock, par value $0.001 per share ("Common Stock"), with 712 shares of Common Stock distributed to each of Messrs. Christopher K. Mirabelli, Douglas E. Onsi and Augustine Lawlor, respectively. Messrs. Mirabelli, Onsi and Lawlor are the Managing Members of Nine Capital Partners and as such, beneficially own and share voting and dispositive power with respect to all of the securities owned by Nine Capital Partners, LLC. F1 · balance_after: Pro rata distribution from Nine Capital Partners, LLC ("Nine Capital Partners") of an aggregate of 2,136 shares of Cypherpunk Technologies Inc. ("Company") common stock, par value $0.001 per share ("Common Stock"), with 712 shares of Common Stock distributed to each of Messrs. Christopher K. Mirabelli, Douglas E. Onsi and Augustine Lawlor, respectively. Messrs. Mirabelli, Onsi and Lawlor are the Managing Members of Nine Capital Partners and as such, beneficially own and share voting and dispositive power with respect to all of the securities owned by Nine Capital Partners, LLC. F1 · ownership.nature: Pro rata distribution from Nine Capital Partners, LLC ("Nine Capital Partners") of an aggregate of 2,136 shares of Cypherpunk Technologies Inc. ("Company") common stock, par value $0.001 per share ("Common Stock"), with 712 shares of Common Stock distributed to each of Messrs. Christopher K. Mirabelli, Douglas E. Onsi and Augustine Lawlor, respectively. Messrs. Mirabelli, Onsi and Lawlor are the Managing Members of Nine Capital Partners and as such, beneficially own and share voting and dispositive power with respect to all of the securities owned by Nine Capital Partners, LLC. F2 · ownership.nature: The reporting person disclaims beneficial ownership of these shares except to the extent of his proportionate pecuniary interest therein. Read SEC document |
| December 23, 2025 Filed Dec 30, 2025 21:36 UTC |
LOSCALZO JOSEPHDirector
|
GrantRestricted Stock Units · Derivative | 94,050 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-125260 · tm2534450-7_4seq1.xml · derivative · entry 1 LOSCALZO JOSEPH · CIK 0001276128 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,050 Underlying: Common Stock · 94,050 shares Expires not disclosed F1 · derivative.exercise_price: Represents restricted stock units ("RSUs") to be settled on a 1 for 1 basis for shares of Cypherpunk Technologies Inc. ("Company") common stock, par value $0.001 per share ("Common Stock"). The RSUs were awarded pursuant to the Company's 2025 Equity Incentive Plan for no consideration. F2 · derivative.exercise_date: The RSUs vested at issuance on December 23, 2025 (the "Grant Date"). Subject to the terms of the RSU award and applicable tax withholdings, the Company shall settle the RSUs for Common Stock as soon as practicable following the earlier to occur of (i) the fifth (5th) business day after the date the reporting person ceases for any reason to be a member of the Company's Board of Directors or (ii) the date of the first annual meeting of stockholders of the Company that occurs following the Grant Date. F2 · derivative.expiration_date: The RSUs vested at issuance on December 23, 2025 (the "Grant Date"). Subject to the terms of the RSU award and applicable tax withholdings, the Company shall settle the RSUs for Common Stock as soon as practicable following the earlier to occur of (i) the fifth (5th) business day after the date the reporting person ceases for any reason to be a member of the Company's Board of Directors or (ii) the date of the first annual meeting of stockholders of the Company that occurs following the Grant Date. Read SEC document |
| December 23, 2025 Filed Dec 30, 2025 21:39 UTC |
Mashiach NissimDirector
|
GrantRestricted Stock Units · Derivative | 94,050 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-125266 · tm2534450-10_4seq1.xml · derivative · entry 1 Mashiach Nissim · CIK 0001357777 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,050 Underlying: Common Stock · 94,050 shares Expires not disclosed F1 · derivative.exercise_price: Represents restricted stock units ("RSUs") to be settled on a 1 for 1 basis for shares of Cypherpunk Technologies Inc. ("Company") common stock, par value $0.001 per share ("Common Stock"). The RSUs were awarded pursuant to the Company's 2025 Equity Incentive Plan for no consideration. F2 · derivative.exercise_date: The RSUs vested at issuance on December 23, 2025 (the "Grant Date"). Subject to the terms of the RSU award and applicable tax withholdings, the Company shall settle the RSUs for Common Stock as soon as practicable following the earlier to occur of (i) the fifth (5th) business day after the date the reporting person ceases for any reason to be a member of the Company's Board of Directors or (ii) the date of the first annual meeting of stockholders of the Company that occurs following the Grant Date. F2 · derivative.expiration_date: The RSUs vested at issuance on December 23, 2025 (the "Grant Date"). Subject to the terms of the RSU award and applicable tax withholdings, the Company shall settle the RSUs for Common Stock as soon as practicable following the earlier to occur of (i) the fifth (5th) business day after the date the reporting person ceases for any reason to be a member of the Company's Board of Directors or (ii) the date of the first annual meeting of stockholders of the Company that occurs following the Grant Date. Read SEC document |
| December 23, 2025 Filed Dec 30, 2025 21:40 UTC |
Richard Christian MDirector
|
GrantRestricted Stock Units · Derivative | 94,050 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-125268 · tm2534450-11_4seq1.xml · derivative · entry 1 Richard Christian M · CIK 0001645967 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,050 Underlying: Common Stock · 94,050 shares Expires not disclosed F1 · derivative.exercise_price: Represents restricted stock units ("RSUs") to be settled on a 1 for 1 basis for shares of Cypherpunk Technologies Inc. ("Company") common stock, par value $0.001 per share ("Common Stock"). The RSUs were awarded pursuant to the Company's 2025 Equity Incentive Plan for no consideration. F2 · derivative.exercise_date: The RSUs vested at issuance on December 23, 2025 (the "Grant Date"). Subject to the terms of the RSU award and applicable tax withholdings, the Company shall settle the RSUs for Common Stock as soon as practicable following the earlier to occur of (i) the fifth (5th) business day after the date the reporting person ceases for any reason to be a member of the Company's Board of Directors or (ii) the date of the first annual meeting of stockholders of the Company that occurs following the Grant Date. F2 · derivative.expiration_date: The RSUs vested at issuance on December 23, 2025 (the "Grant Date"). Subject to the terms of the RSU award and applicable tax withholdings, the Company shall settle the RSUs for Common Stock as soon as practicable following the earlier to occur of (i) the fifth (5th) business day after the date the reporting person ceases for any reason to be a member of the Company's Board of Directors or (ii) the date of the first annual meeting of stockholders of the Company that occurs following the Grant Date. Read SEC document |
| December 23, 2025 Filed Dec 30, 2025 21:38 UTC |
Martin Patricia A.Director
|
GrantRestricted Stock Units · Derivative | 94,050 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-125263 · tm2534450-9_4seq1.xml · derivative · entry 1 Martin Patricia A. · CIK 0001916764 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,050 Underlying: Common Stock · 94,050 shares Expires not disclosed F1 · derivative.exercise_price: Represents restricted stock units ("RSUs") to be settled on a 1 for 1 basis for shares of Cypherpunk Technologies Inc. ("Company") common stock, par value $0.001 per share ("Common Stock"). The RSUs were awarded pursuant to the Company's 2025 Equity Incentive Plan for no consideration. F2 · derivative.exercise_date: The RSUs vested at issuance on December 23, 2025 (the "Grant Date"). Subject to the terms of the RSU award and applicable tax withholdings, the Company shall settle the RSUs for Common Stock as soon as practicable following the earlier to occur of (i) the fifth (5th) business day after the date the reporting person ceases for any reason to be a member of the Company's Board of Directors or (ii) the date of the first annual meeting of stockholders of the Company that occurs following the Grant Date. F2 · derivative.expiration_date: The RSUs vested at issuance on December 23, 2025 (the "Grant Date"). Subject to the terms of the RSU award and applicable tax withholdings, the Company shall settle the RSUs for Common Stock as soon as practicable following the earlier to occur of (i) the fifth (5th) business day after the date the reporting person ceases for any reason to be a member of the Company's Board of Directors or (ii) the date of the first annual meeting of stockholders of the Company that occurs following the Grant Date. Read SEC document |
| December 23, 2025 Filed Dec 30, 2025 21:37 UTC |
Schilsky RichardDirector
|
GrantRestricted Stock Units · Derivative | 94,050 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-125262 · tm2534450-8_4seq1.xml · derivative · entry 1 Schilsky Richard · CIK 0001945662 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,050 Underlying: Common Stock · 94,050 shares Expires not disclosed F1 · derivative.exercise_price: Represents restricted stock units ("RSUs") to be settled on a 1 for 1 basis for shares of Cypherpunk Technologies Inc. ("Company") common stock, par value $0.001 per share ("Common Stock"). The RSUs were awarded pursuant to the Company's 2025 Equity Incentive Plan for no consideration. F2 · derivative.exercise_date: The RSUs vested at issuance on December 23, 2025 (the "Grant Date"). Subject to the terms of the RSU award and applicable tax withholdings, the Company shall settle the RSUs for Common Stock as soon as practicable following the earlier to occur of (i) the fifth (5th) business day after the date the reporting person ceases for any reason to be a member of the Company's Board of Directors or (ii) the date of the first annual meeting of stockholders of the Company that occurs following the Grant Date. F2 · derivative.expiration_date: The RSUs vested at issuance on December 23, 2025 (the "Grant Date"). Subject to the terms of the RSU award and applicable tax withholdings, the Company shall settle the RSUs for Common Stock as soon as practicable following the earlier to occur of (i) the fifth (5th) business day after the date the reporting person ceases for any reason to be a member of the Company's Board of Directors or (ii) the date of the first annual meeting of stockholders of the Company that occurs following the Grant Date. Read SEC document |
| December 23, 2025 Filed Dec 30, 2025 21:33 UTC |
Dietz Thomas JohnDirector
|
GrantRestricted Stock Units · Derivative | 104,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-125256 · tm2534450-5_4seq1.xml · derivative · entry 4 Dietz Thomas John · CIK 0001574218 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,500 Underlying: Common Stock · 104,500 shares Expires not disclosed F4 · derivative.exercise_price: Represents RSUs to be settled on a 1 for 1 basis for shares of Company Common Stock. The RSUs (the "December 2025 RSUs") were awarded pursuant to the Company's 2025 Equity Incentive Plan for no consideration. F5 · derivative.exercise_date: The December 2025 RSUs vested at issuance on December 23, 2025 (the "Grant Date"). Subject to the terms of the December 2025 RSU award and applicable tax withholdings, the Company shall settle the December 2025 RSUs for Common Stock as soon as practicable following the earlier to occur of (i) the fifth (5th) business day after the date the reporting person ceases for any reason to be a member of the Company's Board of Directors or (ii) the date of the first annual meeting of stockholders of the Company that occurs following the Grant Date. F5 · derivative.expiration_date: The December 2025 RSUs vested at issuance on December 23, 2025 (the "Grant Date"). Subject to the terms of the December 2025 RSU award and applicable tax withholdings, the Company shall settle the December 2025 RSUs for Common Stock as soon as practicable following the earlier to occur of (i) the fifth (5th) business day after the date the reporting person ceases for any reason to be a member of the Company's Board of Directors or (ii) the date of the first annual meeting of stockholders of the Company that occurs following the Grant Date. Read SEC document |
| December 23, 2025 Filed Dec 30, 2025 21:32 UTC |
McEvoy William Patrick IIIDirector · Chief Investment Officer · 10% owner
|
GrantRestricted Stock Units · Derivative | 5,616,907 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-125255 · tm2534450-4_4seq1.xml · derivative · entry 1 McEvoy William Patrick III · CIK 0002092596 · Director · Chief Investment Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,616,907 Underlying: Common Stock · 5,616,907 shares Expires not disclosed F1 · derivative.exercise_price: Represents restricted stock units ("RSUs") to be settled on a 1 for 1 basis for shares of Cypherpunk Technologies Inc. ("Company") common stock, par value $0.001 per share ("Common Stock"). The RSUs were awarded pursuant to the Executive Employment Agreement, dated November 11, 2025, by and between the Company and the reporting person (the "Employment Agreement") and issued under the Company's 2025 Equity Incentive Plan for no consideration. F2 · derivative.exercise_date: The RSUs will vest at (i) 12/36th on October 8, 2026 and (ii) 1/36th on the eighth (8th) day of each month thereafter (each, a "Vesting Date"), subject to the reporting person's continued service with the Company. Subject to the terms of the Employment Agreement, the RSU award and applicable tax withholdings, the Company shall settle vested RSUs for Common Stock on the earliest to occur of (i) the first payroll period on or after the date the reporting person's employment with or service to the Company ceases, (ii) the first payroll period on or after the eighth (8th) day of the calendar month of June following any such Vesting Date applicable to such vested RSU or (iii) the first payroll period on or after the eighth (8th) day of the month of December following any such Vesting Date. F2 · derivative.expiration_date: The RSUs will vest at (i) 12/36th on October 8, 2026 and (ii) 1/36th on the eighth (8th) day of each month thereafter (each, a "Vesting Date"), subject to the reporting person's continued service with the Company. Subject to the terms of the Employment Agreement, the RSU award and applicable tax withholdings, the Company shall settle vested RSUs for Common Stock on the earliest to occur of (i) the first payroll period on or after the date the reporting person's employment with or service to the Company ceases, (ii) the first payroll period on or after the eighth (8th) day of the calendar month of June following any such Vesting Date applicable to such vested RSU or (iii) the first payroll period on or after the eighth (8th) day of the month of December following any such Vesting Date. Read SEC document |
| December 23, 2025 Filed Dec 30, 2025 21:29 UTC |
Oei Khing DjienDirector
|
GrantRestricted Stock Units · Derivative | 5,448,157 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-125247 · tm2534450-1_4seq1.xml · derivative · entry 3 Oei Khing Djien · CIK 0002092424 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By CoinXit Ltd Disclosed balance after: 5,448,157 Underlying: Common Stock · 5,448,157 shares Expires not disclosed F1 · derivative.exercise_price: Represents restricted stock units ("RSUs") to be settled on a 1 for 1 basis for shares of Cypherpunk Technologies Inc. ("Company") common stock, par value $0.001 per share ("Common Stock"). F4 · derivative.exercise_price: Includes (i) 2,411,700 First RSUs and (ii) 3,036,457 RSUs due to CoinXit pursuant to the Consulting Agreement (the "Second RSUs", and together with the First RSUs, the "CoinXit RSUs"). The CoinXit RSUs were awarded to CoinXit December 23, 2025 pursuant to the Consulting Agreement, and were issued under the Company's 2025 Equity Incentive Plan. F4 · shares: Includes (i) 2,411,700 First RSUs and (ii) 3,036,457 RSUs due to CoinXit pursuant to the Consulting Agreement (the "Second RSUs", and together with the First RSUs, the "CoinXit RSUs"). The CoinXit RSUs were awarded to CoinXit December 23, 2025 pursuant to the Consulting Agreement, and were issued under the Company's 2025 Equity Incentive Plan. F5 · derivative.exercise_date: The CoinXit RSUs will vest at (i) 12/36th on October 8, 2026 and (ii) 1/36th on the eighth (8th) day of each month thereafter (each, a "Vesting Date"), subject to the reporting person's continued service with or to the Company. Subject to the terms of the CoinXit RSU award and applicable tax withholdings, the Company shall settle vested CoinXit RSUs for Common Stock on the earliest to occur of (i) the first payroll period on or after the date the reporting person's employment with or service to the Company ceases, (ii) the first payroll period on or after the eighth (8th) day of the calendar month of June following any such Vesting Date applicable to such vested CoinXit RSU or (iii) the first payroll period on or after the eighth (8th) day of the month of December following any such Vesting Date. The reporting person is the director and sole owner of CoinXit, and disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. F5 · derivative.expiration_date: The CoinXit RSUs will vest at (i) 12/36th on October 8, 2026 and (ii) 1/36th on the eighth (8th) day of each month thereafter (each, a "Vesting Date"), subject to the reporting person's continued service with or to the Company. Subject to the terms of the CoinXit RSU award and applicable tax withholdings, the Company shall settle vested CoinXit RSUs for Common Stock on the earliest to occur of (i) the first payroll period on or after the date the reporting person's employment with or service to the Company ceases, (ii) the first payroll period on or after the eighth (8th) day of the calendar month of June following any such Vesting Date applicable to such vested CoinXit RSU or (iii) the first payroll period on or after the eighth (8th) day of the month of December following any such Vesting Date. The reporting person is the director and sole owner of CoinXit, and disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. F4 · ownership.nature: Includes (i) 2,411,700 First RSUs and (ii) 3,036,457 RSUs due to CoinXit pursuant to the Consulting Agreement (the "Second RSUs", and together with the First RSUs, the "CoinXit RSUs"). The CoinXit RSUs were awarded to CoinXit December 23, 2025 pursuant to the Consulting Agreement, and were issued under the Company's 2025 Equity Incentive Plan. F5 · ownership.nature: The CoinXit RSUs will vest at (i) 12/36th on October 8, 2026 and (ii) 1/36th on the eighth (8th) day of each month thereafter (each, a "Vesting Date"), subject to the reporting person's continued service with or to the Company. Subject to the terms of the CoinXit RSU award and applicable tax withholdings, the Company shall settle vested CoinXit RSUs for Common Stock on the earliest to occur of (i) the first payroll period on or after the date the reporting person's employment with or service to the Company ceases, (ii) the first payroll period on or after the eighth (8th) day of the calendar month of June following any such Vesting Date applicable to such vested CoinXit RSU or (iii) the first payroll period on or after the eighth (8th) day of the month of December following any such Vesting Date. The reporting person is the director and sole owner of CoinXit, and disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| December 23, 2025 Filed Dec 30, 2025 21:29 UTC |
Oei Khing DjienDirector
|
Disposition to issuerRestricted Stock Units · Derivative | 2,411,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-125247 · tm2534450-1_4seq1.xml · derivative · entry 2 Oei Khing Djien · CIK 0002092424 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By CoinXit Ltd Disclosed balance after: 0 Underlying: Common Stock · 2,411,700 shares Expires not disclosed F1 · derivative.exercise_price: Represents restricted stock units ("RSUs") to be settled on a 1 for 1 basis for shares of Cypherpunk Technologies Inc. ("Company") common stock, par value $0.001 per share ("Common Stock"). F3 · derivative.exercise_price: The 2,411,700 RSUs (the "First RSUs") were previously awarded to CoinXit Ltd ("CoinXit") pursuant to the Consulting Agreement, dated October 6, 2025, by and between the Company and CoinXit (the "Consulting Agreement"), and were issued under the Company's 2022 Equity Incentive Plan. On December 23, 2025, the Company and CoinXit agreed to terminate the agreement representing the First RSUs and to combine the First RSUs with the Second RSUs (as defined below), into a single RSU award of 5,448,157 RSUs to be issued under the 2025 Plan, in full satisfaction of the Company's obligations under the Consulting Agreement. F3 · shares: The 2,411,700 RSUs (the "First RSUs") were previously awarded to CoinXit Ltd ("CoinXit") pursuant to the Consulting Agreement, dated October 6, 2025, by and between the Company and CoinXit (the "Consulting Agreement"), and were issued under the Company's 2022 Equity Incentive Plan. On December 23, 2025, the Company and CoinXit agreed to terminate the agreement representing the First RSUs and to combine the First RSUs with the Second RSUs (as defined below), into a single RSU award of 5,448,157 RSUs to be issued under the 2025 Plan, in full satisfaction of the Company's obligations under the Consulting Agreement. F3 · derivative.exercise_date: The 2,411,700 RSUs (the "First RSUs") were previously awarded to CoinXit Ltd ("CoinXit") pursuant to the Consulting Agreement, dated October 6, 2025, by and between the Company and CoinXit (the "Consulting Agreement"), and were issued under the Company's 2022 Equity Incentive Plan. On December 23, 2025, the Company and CoinXit agreed to terminate the agreement representing the First RSUs and to combine the First RSUs with the Second RSUs (as defined below), into a single RSU award of 5,448,157 RSUs to be issued under the 2025 Plan, in full satisfaction of the Company's obligations under the Consulting Agreement. F3 · derivative.expiration_date: The 2,411,700 RSUs (the "First RSUs") were previously awarded to CoinXit Ltd ("CoinXit") pursuant to the Consulting Agreement, dated October 6, 2025, by and between the Company and CoinXit (the "Consulting Agreement"), and were issued under the Company's 2022 Equity Incentive Plan. On December 23, 2025, the Company and CoinXit agreed to terminate the agreement representing the First RSUs and to combine the First RSUs with the Second RSUs (as defined below), into a single RSU award of 5,448,157 RSUs to be issued under the 2025 Plan, in full satisfaction of the Company's obligations under the Consulting Agreement. F3 · ownership.nature: The 2,411,700 RSUs (the "First RSUs") were previously awarded to CoinXit Ltd ("CoinXit") pursuant to the Consulting Agreement, dated October 6, 2025, by and between the Company and CoinXit (the "Consulting Agreement"), and were issued under the Company's 2022 Equity Incentive Plan. On December 23, 2025, the Company and CoinXit agreed to terminate the agreement representing the First RSUs and to combine the First RSUs with the Second RSUs (as defined below), into a single RSU award of 5,448,157 RSUs to be issued under the 2025 Plan, in full satisfaction of the Company's obligations under the Consulting Agreement. Read SEC document |
| December 23, 2025 Filed Dec 30, 2025 21:29 UTC |
Oei Khing DjienDirector
|
GrantRestricted Stock Units · Derivative | 94,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-125247 · tm2534450-1_4seq1.xml · derivative · entry 1 Oei Khing Djien · CIK 0002092424 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,050 Underlying: Common Stock · 94,050 shares Expires not disclosed F1 · derivative.exercise_price: Represents restricted stock units ("RSUs") to be settled on a 1 for 1 basis for shares of Cypherpunk Technologies Inc. ("Company") common stock, par value $0.001 per share ("Common Stock"). F2 · derivative.exercise_price: The RSUs were awarded pursuant to the Company's 2025 Equity Incentive Plan (the "2025 Plan") for no consideration. The RSUs vested at issuance on December 23, 2025 (the "Grant Date"). Subject to the terms of the RSU award and applicable tax withholdings, the Company shall settle the RSUs for Common Stock as soon as practicable following the earlier to occur of (i) the fifth (5th) business day after the date the reporting person ceases for any reason to be a member of the Company's Board of Directors or (ii) the date of the first annual meeting of stockholders of the Company that occurs following the Grant Date. F2 · derivative.exercise_date: The RSUs were awarded pursuant to the Company's 2025 Equity Incentive Plan (the "2025 Plan") for no consideration. The RSUs vested at issuance on December 23, 2025 (the "Grant Date"). Subject to the terms of the RSU award and applicable tax withholdings, the Company shall settle the RSUs for Common Stock as soon as practicable following the earlier to occur of (i) the fifth (5th) business day after the date the reporting person ceases for any reason to be a member of the Company's Board of Directors or (ii) the date of the first annual meeting of stockholders of the Company that occurs following the Grant Date. F2 · derivative.expiration_date: The RSUs were awarded pursuant to the Company's 2025 Equity Incentive Plan (the "2025 Plan") for no consideration. The RSUs vested at issuance on December 23, 2025 (the "Grant Date"). Subject to the terms of the RSU award and applicable tax withholdings, the Company shall settle the RSUs for Common Stock as soon as practicable following the earlier to occur of (i) the fifth (5th) business day after the date the reporting person ceases for any reason to be a member of the Company's Board of Directors or (ii) the date of the first annual meeting of stockholders of the Company that occurs following the Grant Date. Read SEC document |
| November 17, 2025 Filed Nov 19, 2025 16:05 UTC |
CAVANAUGH JAMES HDirector
|
SaleCommon Stock | 261,840 | $3.14 | $822,177.60 |
DisclosureSEC source: 0001104659-25-114093 · tm2531740-2_4seq1.xml · nonDerivative · entry 1 CAVANAUGH JAMES H · CIK 0001013473 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 0 F1 · shares: On November 17, 2025, HCV VIII Liquidating Trust ("HCV Liquidating Trust") sold 261,840 shares of the Issuer's common stock at a price of $3.14 per share as a part of a liquidating distribution in connection with the wind up and liquidation of the entity. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.40 to $3.40. The reporting person undertakes to provide to the Issuer, any security holders of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this Form 4. F1 · price: On November 17, 2025, HCV VIII Liquidating Trust ("HCV Liquidating Trust") sold 261,840 shares of the Issuer's common stock at a price of $3.14 per share as a part of a liquidating distribution in connection with the wind up and liquidation of the entity. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.40 to $3.40. The reporting person undertakes to provide to the Issuer, any security holders of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this Form 4. F1 · balance_after: On November 17, 2025, HCV VIII Liquidating Trust ("HCV Liquidating Trust") sold 261,840 shares of the Issuer's common stock at a price of $3.14 per share as a part of a liquidating distribution in connection with the wind up and liquidation of the entity. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.40 to $3.40. The reporting person undertakes to provide to the Issuer, any security holders of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this Form 4. F1 · ownership.nature: On November 17, 2025, HCV VIII Liquidating Trust ("HCV Liquidating Trust") sold 261,840 shares of the Issuer's common stock at a price of $3.14 per share as a part of a liquidating distribution in connection with the wind up and liquidation of the entity. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.40 to $3.40. The reporting person undertakes to provide to the Issuer, any security holders of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this Form 4. F2 · ownership.nature: The reporting person is a beneficiary of the HCV Liquidating Trust and may be deemed to have had beneficial ownership of the 261,840 shares of common stock sold by the HCV Liquidating Trust. The reporting person disclaims beneficial ownership of such shares of common sold by HCV Liquidating Trust, except to the extent of the reporting person's proportionate pecuniary interest therein. Read SEC document |
| November 17, 2025 Filed Nov 19, 2025 21:05 UTC |
ONSI DOUGLAS EDirector · CEO,CFO,Pres.,GC,Treas.&Sec.
|
SaleCommon Stock | 414,479 | $3.14 | $1,301,464.06 |
DisclosureSEC source: 0001104659-25-114084 · tm2531740-1_4seq1.xml · nonDerivative · entry 2 ONSI DOUGLAS E · CIK 0001270185 · Director · CEO,CFO,Pres.,GC,Treas.&Sec. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 2,136 F2 · shares: On November 17, 2025, HealthCare Ventures IX, L.P. ("HCV IX") sold 414,479 shares of the Issuer's common stock at a price of $3.14 per share as a part of a liquidating distribution in connection with the wind up and liquidation of the entity. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.40 to $3.40. The reporting person undertakes to provide to the Issuer, any security holders of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this Form 4. F3 · shares: Reflects a de minimis adjustment of one (1) share due to rounding. F2 · price: On November 17, 2025, HealthCare Ventures IX, L.P. ("HCV IX") sold 414,479 shares of the Issuer's common stock at a price of $3.14 per share as a part of a liquidating distribution in connection with the wind up and liquidation of the entity. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.40 to $3.40. The reporting person undertakes to provide to the Issuer, any security holders of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this Form 4. F2 · balance_after: On November 17, 2025, HealthCare Ventures IX, L.P. ("HCV IX") sold 414,479 shares of the Issuer's common stock at a price of $3.14 per share as a part of a liquidating distribution in connection with the wind up and liquidation of the entity. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.40 to $3.40. The reporting person undertakes to provide to the Issuer, any security holders of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this Form 4. F3 · balance_after: Reflects a de minimis adjustment of one (1) share due to rounding. F2 · ownership.nature: On November 17, 2025, HealthCare Ventures IX, L.P. ("HCV IX") sold 414,479 shares of the Issuer's common stock at a price of $3.14 per share as a part of a liquidating distribution in connection with the wind up and liquidation of the entity. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.40 to $3.40. The reporting person undertakes to provide to the Issuer, any security holders of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this Form 4. F3 · ownership.nature: Reflects a de minimis adjustment of one (1) share due to rounding. F4 · ownership.nature: The reporting person is a managing member of Nine Capital Partners and may be deemed to have beneficial ownership of such 2,136 shares of common stock held by Nine Capital Partners. The reporting person is a Managing Director of HCPIX LLC, which is the General Partner of HealthCare Partners IX, which is the General Partner of HCV IX and may be deemed to have had beneficial ownership of the 414,479 shares of Common Stock sold by HCV IX. The reporting person is a beneficiary of the HCV Liquidating Trust and may be deemed to have had beneficial ownership of the 261,840 shares of Common Stock sold by the HCV Liquidating Trust. The reporting person disclaims beneficial ownership of such shares of common stock held by Nine Capital Partners, and sold by each of HCV IX and the HCV Liquidating Trust, except to the extent of the reporting person's proportionate pecuniary interest therein. Read SEC document |
| November 17, 2025 Filed Nov 19, 2025 21:05 UTC |
ONSI DOUGLAS EDirector · CEO,CFO,Pres.,GC,Treas.&Sec.
|
SaleCommon Stock | 261,840 | $3.14 | $822,177.60 |
DisclosureSEC source: 0001104659-25-114084 · tm2531740-1_4seq1.xml · nonDerivative · entry 1 ONSI DOUGLAS E · CIK 0001270185 · Director · CEO,CFO,Pres.,GC,Treas.&Sec. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 416,616 F1 · shares: On November 17, 2025, HCV VIII Liquidating Trust ("HCV Liquidating Trust") sold 261,840 shares of the Issuer's common stock at a price of $3.14 per share as a part of a liquidating distribution in connection with the wind up and liquidation of the entity. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.40 to $3.40. The reporting person undertakes to provide to the Issuer, any security holders of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this Form 4. F1 · price: On November 17, 2025, HCV VIII Liquidating Trust ("HCV Liquidating Trust") sold 261,840 shares of the Issuer's common stock at a price of $3.14 per share as a part of a liquidating distribution in connection with the wind up and liquidation of the entity. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.40 to $3.40. The reporting person undertakes to provide to the Issuer, any security holders of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this Form 4. F1 · balance_after: On November 17, 2025, HCV VIII Liquidating Trust ("HCV Liquidating Trust") sold 261,840 shares of the Issuer's common stock at a price of $3.14 per share as a part of a liquidating distribution in connection with the wind up and liquidation of the entity. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.40 to $3.40. The reporting person undertakes to provide to the Issuer, any security holders of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this Form 4. F1 · ownership.nature: On November 17, 2025, HCV VIII Liquidating Trust ("HCV Liquidating Trust") sold 261,840 shares of the Issuer's common stock at a price of $3.14 per share as a part of a liquidating distribution in connection with the wind up and liquidation of the entity. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.40 to $3.40. The reporting person undertakes to provide to the Issuer, any security holders of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this Form 4. F2 · ownership.nature: On November 17, 2025, HealthCare Ventures IX, L.P. ("HCV IX") sold 414,479 shares of the Issuer's common stock at a price of $3.14 per share as a part of a liquidating distribution in connection with the wind up and liquidation of the entity. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.40 to $3.40. The reporting person undertakes to provide to the Issuer, any security holders of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this Form 4. F4 · ownership.nature: The reporting person is a managing member of Nine Capital Partners and may be deemed to have beneficial ownership of such 2,136 shares of common stock held by Nine Capital Partners. The reporting person is a Managing Director of HCPIX LLC, which is the General Partner of HealthCare Partners IX, which is the General Partner of HCV IX and may be deemed to have had beneficial ownership of the 414,479 shares of Common Stock sold by HCV IX. The reporting person is a beneficiary of the HCV Liquidating Trust and may be deemed to have had beneficial ownership of the 261,840 shares of Common Stock sold by the HCV Liquidating Trust. The reporting person disclaims beneficial ownership of such shares of common stock held by Nine Capital Partners, and sold by each of HCV IX and the HCV Liquidating Trust, except to the extent of the reporting person's proportionate pecuniary interest therein. Read SEC document |
| November 17, 2025 Filed Nov 19, 2025 16:06 UTC |
Mirabelli ChristopherDirector
|
SaleCommon Stock | 414,479 | $3.14 | $1,301,464.06 |
DisclosureSEC source: 0001104659-25-114094 · tm2531740-3_4seq1.xml · nonDerivative · entry 2 Mirabelli Christopher · CIK 0001262326 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 2,136 F2 · shares: On November 17, 2025, HealthCare Ventures IX, L.P. ("HCV IX") sold 414,479 shares of the Issuer's common stock at a price of $3.14 per share as a part of a liquidating distribution in connection with the wind up and liquidation of the entity. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.40 to $3.40. The reporting person undertakes to provide to the Issuer, any security holders of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this Form 4. F3 · shares: Reflects a de minimis adjustment of one (1) share due to rounding. F2 · price: On November 17, 2025, HealthCare Ventures IX, L.P. ("HCV IX") sold 414,479 shares of the Issuer's common stock at a price of $3.14 per share as a part of a liquidating distribution in connection with the wind up and liquidation of the entity. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.40 to $3.40. The reporting person undertakes to provide to the Issuer, any security holders of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this Form 4. F2 · balance_after: On November 17, 2025, HealthCare Ventures IX, L.P. ("HCV IX") sold 414,479 shares of the Issuer's common stock at a price of $3.14 per share as a part of a liquidating distribution in connection with the wind up and liquidation of the entity. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.40 to $3.40. The reporting person undertakes to provide to the Issuer, any security holders of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this Form 4. F3 · balance_after: Reflects a de minimis adjustment of one (1) share due to rounding. F2 · ownership.nature: On November 17, 2025, HealthCare Ventures IX, L.P. ("HCV IX") sold 414,479 shares of the Issuer's common stock at a price of $3.14 per share as a part of a liquidating distribution in connection with the wind up and liquidation of the entity. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.40 to $3.40. The reporting person undertakes to provide to the Issuer, any security holders of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this Form 4. F3 · ownership.nature: Reflects a de minimis adjustment of one (1) share due to rounding. F4 · ownership.nature: The reporting person is a managing member of Nine Capital Partners and may be deemed to have beneficial ownership of such 2,136 shares of common stock held by Nine Capital Partners. The reporting person is a Managing Director of HCPIX LLC, which is the General Partner of HealthCare Partners IX, which is the General Partner of HCV IX and may be deemed to have had beneficial ownership of the 414,479 shares of Common Stock sold by HCV IX. The reporting person is a beneficiary of the HCV Liquidating Trust and may be deemed to have had beneficial ownership of the 261,840 shares of Common Stock sold by the HCV Liquidating Trust. The reporting person disclaims beneficial ownership of such shares of common stock held by Nine Capital Partners, and sold by each of HCV IX and the HCV Liquidating Trust, except to the extent of the reporting person's proportionate pecuniary interest therein. Read SEC document |
| November 17, 2025 Filed Nov 19, 2025 16:06 UTC |
Mirabelli ChristopherDirector
|
SaleCommon Stock | 261,840 | $3.14 | $822,177.60 |
DisclosureSEC source: 0001104659-25-114094 · tm2531740-3_4seq1.xml · nonDerivative · entry 1 Mirabelli Christopher · CIK 0001262326 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 416,616 F1 · shares: On November 17, 2025, HCV VIII Liquidating Trust ("HCV Liquidating Trust") sold 261,840 shares of the Issuer's common stock at a price of $3.14 per share as a part of a liquidating distribution in connection with the wind up and liquidation of the entity. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.40 to $3.40. The reporting person undertakes to provide to the Issuer, any security holders of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this Form 4. F1 · price: On November 17, 2025, HCV VIII Liquidating Trust ("HCV Liquidating Trust") sold 261,840 shares of the Issuer's common stock at a price of $3.14 per share as a part of a liquidating distribution in connection with the wind up and liquidation of the entity. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.40 to $3.40. The reporting person undertakes to provide to the Issuer, any security holders of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this Form 4. F1 · balance_after: On November 17, 2025, HCV VIII Liquidating Trust ("HCV Liquidating Trust") sold 261,840 shares of the Issuer's common stock at a price of $3.14 per share as a part of a liquidating distribution in connection with the wind up and liquidation of the entity. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.40 to $3.40. The reporting person undertakes to provide to the Issuer, any security holders of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this Form 4. F1 · ownership.nature: On November 17, 2025, HCV VIII Liquidating Trust ("HCV Liquidating Trust") sold 261,840 shares of the Issuer's common stock at a price of $3.14 per share as a part of a liquidating distribution in connection with the wind up and liquidation of the entity. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.40 to $3.40. The reporting person undertakes to provide to the Issuer, any security holders of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this Form 4. F2 · ownership.nature: On November 17, 2025, HealthCare Ventures IX, L.P. ("HCV IX") sold 414,479 shares of the Issuer's common stock at a price of $3.14 per share as a part of a liquidating distribution in connection with the wind up and liquidation of the entity. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.40 to $3.40. The reporting person undertakes to provide to the Issuer, any security holders of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this Form 4. F4 · ownership.nature: The reporting person is a managing member of Nine Capital Partners and may be deemed to have beneficial ownership of such 2,136 shares of common stock held by Nine Capital Partners. The reporting person is a Managing Director of HCPIX LLC, which is the General Partner of HealthCare Partners IX, which is the General Partner of HCV IX and may be deemed to have had beneficial ownership of the 414,479 shares of Common Stock sold by HCV IX. The reporting person is a beneficiary of the HCV Liquidating Trust and may be deemed to have had beneficial ownership of the 261,840 shares of Common Stock sold by the HCV Liquidating Trust. The reporting person disclaims beneficial ownership of such shares of common stock held by Nine Capital Partners, and sold by each of HCV IX and the HCV Liquidating Trust, except to the extent of the reporting person's proportionate pecuniary interest therein. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 16:55 UTC |
CAVANAUGH JAMES HDirector
|
GrantRestricted Stock Units · Derivative | 74,700 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-111438 · tm2531210-5_4seq1.xml · derivative · entry 1 CAVANAUGH JAMES H · CIK 0001013473 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,700 Underlying: Common Stock · 74,700 shares Expires not disclosed F1 · derivative.exercise_price: Represents restricted stock units ("RSUs") to be settled on a 1 for 1 basis for shares of Cypherpunk Technologies Inc. ("Company") common stock, par value $0.001 per share ("Common Stock"). The RSUs were awarded pursuant to the Company's 2022 Equity Incentive Plan for no consideration. F2 · derivative.exercise_date: The RSUs vested at issuance on November 11, 2025 (the "Grant Date"). Subject to the terms of the RSU award and applicable tax withholdings, the Company shall settle the RSUs for Common Stock as soon as practicable following the earlier to occur of (i) the fifth (5th) business day after the date the reporting person ceases for any reason to be a member of the Company's Board of Directors or (ii) the date of the first annual meeting of stockholders of the Company that occurs following the Grant Date. F2 · derivative.expiration_date: The RSUs vested at issuance on November 11, 2025 (the "Grant Date"). Subject to the terms of the RSU award and applicable tax withholdings, the Company shall settle the RSUs for Common Stock as soon as practicable following the earlier to occur of (i) the fifth (5th) business day after the date the reporting person ceases for any reason to be a member of the Company's Board of Directors or (ii) the date of the first annual meeting of stockholders of the Company that occurs following the Grant Date. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 22:01 UTC |
LI WILLIAMDirector
|
GrantRestricted Stock Units · Derivative | 74,700 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-111458 · tm2531210-11_4seq1.xml · derivative · entry 1 LI WILLIAM · CIK 0001273806 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,700 Underlying: Common Stock · 74,700 shares Expires not disclosed F1 · derivative.exercise_price: Represents restricted stock units ("RSUs") to be settled on a 1 for 1 basis for shares of Cypherpunk Technologies Inc. ("Company") common stock, par value $0.001 per share ("Common Stock"). The RSUs were awarded pursuant to the Company's 2022 Equity Incentive Plan for no consideration. F2 · derivative.exercise_date: The RSUs vested at issuance on November 11, 2025 (the "Grant Date"). Subject to the terms of the RSU award and applicable tax withholdings, the Company shall settle the RSUs for Common Stock as soon as practicable following the earlier to occur of (i) the fifth (5th) business day after the date the reporting person ceases for any reason to be a member of the Company's Board of Directors or (ii) the date of the first annual meeting of stockholders of the Company that occurs following the Grant Date. F2 · derivative.expiration_date: The RSUs vested at issuance on November 11, 2025 (the "Grant Date"). Subject to the terms of the RSU award and applicable tax withholdings, the Company shall settle the RSUs for Common Stock as soon as practicable following the earlier to occur of (i) the fifth (5th) business day after the date the reporting person ceases for any reason to be a member of the Company's Board of Directors or (ii) the date of the first annual meeting of stockholders of the Company that occurs following the Grant Date. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 22:02 UTC |
ONSI DOUGLAS EDirector · CEO,CFO,Pres.,GC,Treas.&Sec.
|
GrantRestricted Stock Units · Derivative | 2,087,287 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-111461 · tm2531210-12_4seq1.xml · derivative · entry 1 ONSI DOUGLAS E · CIK 0001270185 · Director · CEO,CFO,Pres.,GC,Treas.&Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,087,287 Underlying: Common Stock · 2,087,287 shares Expires not disclosed F1 · derivative.exercise_price: Represents restricted stock units ("RSUs") to be settled on a 1 for 1 basis for shares of Cypherpunk Technologies Inc. ("Company") common stock, par value $0.001 per share ("Common Stock"). The RSUs were awarded pursuant to the Company's 2016 Equity Incentive Plan for no consideration. F2 · derivative.exercise_date: The RSUs will vest at (i) 12/36th on October 8, 2026 and (ii) 1/36th on the eighth (8th) day of each month thereafter (each, a "Vesting Date"), subject to the reporting person's continued service with the Company. Subject to the terms of the RSU award and applicable tax withholdings, the Company shall settle vested RSUs for Common Stock on the earliest to occur of (i) the first payroll period on or after the date the reporting person's employment with or service to the Company ceases, (ii) the first payroll period on or after the eighth (8th) day of the calendar month of June following any such Vesting Date applicable to such vested RSU or (iii) the first payroll period on or after the eighth (8th) day of the month of December following any such Vesting Date. F2 · derivative.expiration_date: The RSUs will vest at (i) 12/36th on October 8, 2026 and (ii) 1/36th on the eighth (8th) day of each month thereafter (each, a "Vesting Date"), subject to the reporting person's continued service with the Company. Subject to the terms of the RSU award and applicable tax withholdings, the Company shall settle vested RSUs for Common Stock on the earliest to occur of (i) the first payroll period on or after the date the reporting person's employment with or service to the Company ceases, (ii) the first payroll period on or after the eighth (8th) day of the calendar month of June following any such Vesting Date applicable to such vested RSU or (iii) the first payroll period on or after the eighth (8th) day of the month of December following any such Vesting Date. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 16:54 UTC |
Mirabelli ChristopherDirector
|
GrantRestricted Stock Units · Derivative | 74,700 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-111434 · tm2531210-4_4seq1.xml · derivative · entry 1 Mirabelli Christopher · CIK 0001262326 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,700 Underlying: Common Stock · 74,700 shares Expires not disclosed F1 · derivative.exercise_price: Represents restricted stock units ("RSUs") to be settled on a 1 for 1 basis for shares of Cypherpunk Technologies Inc. ("Company") common stock, par value $0.001 per share ("Common Stock"). The RSUs were awarded pursuant to the Company's 2016 Equity Incentive Plan for no consideration. F2 · derivative.exercise_date: The RSUs vested at issuance on November 11, 2025 (the "Grant Date"). Subject to the terms of the RSU award and applicable tax withholdings, the Company shall settle the RSUs for Common Stock as soon as practicable following the earlier to occur of (i) the fifth (5th) business day after the date the reporting person ceases for any reason to be a member of the Company's Board of Directors or (ii) the date of the first annual meeting of stockholders of the Company that occurs following the Grant Date. F2 · derivative.expiration_date: The RSUs vested at issuance on November 11, 2025 (the "Grant Date"). Subject to the terms of the RSU award and applicable tax withholdings, the Company shall settle the RSUs for Common Stock as soon as practicable following the earlier to occur of (i) the fifth (5th) business day after the date the reporting person ceases for any reason to be a member of the Company's Board of Directors or (ii) the date of the first annual meeting of stockholders of the Company that occurs following the Grant Date. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 21:56 UTC |
LOSCALZO JOSEPHDirector
|
GrantRestricted Stock Units · Derivative | 74,700 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-111440 · tm2531210-6_4seq1.xml · derivative · entry 1 LOSCALZO JOSEPH · CIK 0001276128 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,700 Underlying: Common Stock · 74,700 shares Expires not disclosed F1 · derivative.exercise_price: Represents restricted stock units ("RSUs") to be settled on a 1 for 1 basis for shares of Cypherpunk Technologies Inc. ("Company") common stock, par value $0.001 per share ("Common Stock"). The RSUs were awarded pursuant to the Company's 2022 Equity Incentive Plan for no consideration. F2 · derivative.exercise_date: The RSUs vested at issuance on November 11, 2025 (the "Grant Date"). Subject to the terms of the RSU award and applicable tax withholdings, the Company shall settle the RSUs for Common Stock as soon as practicable following the earlier to occur of (i) the fifth (5th) business day after the date the reporting person ceases for any reason to be a member of the Company's Board of Directors or (ii) the date of the first annual meeting of stockholders of the Company that occurs following the Grant Date. F2 · derivative.expiration_date: The RSUs vested at issuance on November 11, 2025 (the "Grant Date"). Subject to the terms of the RSU award and applicable tax withholdings, the Company shall settle the RSUs for Common Stock as soon as practicable following the earlier to occur of (i) the fifth (5th) business day after the date the reporting person ceases for any reason to be a member of the Company's Board of Directors or (ii) the date of the first annual meeting of stockholders of the Company that occurs following the Grant Date. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 21:58 UTC |
Mashiach NissimDirector
|
GrantRestricted Stock Units · Derivative | 74,700 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-111449 · tm2531210-9_4seq1.xml · derivative · entry 1 Mashiach Nissim · CIK 0001357777 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,700 Underlying: Common Stock · 74,700 shares Expires not disclosed F1 · derivative.exercise_price: Represents restricted stock units ("RSUs") to be settled on a 1 for 1 basis for shares of Cypherpunk Technologies Inc. ("Company") common stock, par value $0.001 per share ("Common Stock"). The RSUs were awarded pursuant to the Company's 2022 Equity Incentive Plan for no consideration. F2 · derivative.exercise_date: The RSUs vested at issuance on November 11, 2025 (the "Grant Date"). Subject to the terms of the RSU award and applicable tax withholdings, the Company shall settle the RSUs for Common Stock as soon as practicable following the earlier to occur of (i) the fifth (5th) business day after the date the reporting person ceases for any reason to be a member of the Company's Board of Directors or (ii) the date of the first annual meeting of stockholders of the Company that occurs following the Grant Date. F2 · derivative.expiration_date: The RSUs vested at issuance on November 11, 2025 (the "Grant Date"). Subject to the terms of the RSU award and applicable tax withholdings, the Company shall settle the RSUs for Common Stock as soon as practicable following the earlier to occur of (i) the fifth (5th) business day after the date the reporting person ceases for any reason to be a member of the Company's Board of Directors or (ii) the date of the first annual meeting of stockholders of the Company that occurs following the Grant Date. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 21:59 UTC |
Richard Christian MDirector
|
GrantRestricted Stock Units · Derivative | 74,700 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-111452 · tm2531210-10_4seq1.xml · derivative · entry 1 Richard Christian M · CIK 0001645967 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,700 Underlying: Common Stock · 74,700 shares Expires not disclosed F1 · derivative.exercise_price: Represents restricted stock units ("RSUs") to be settled on a 1 for 1 basis for shares of Cypherpunk Technologies Inc. ("Company") common stock, par value $0.001 per share ("Common Stock"). The RSUs were awarded pursuant to the Company's 2022 Equity Incentive Plan for no consideration. F2 · derivative.exercise_date: The RSUs vested at issuance on November 11, 2025 (the "Grant Date"). Subject to the terms of the RSU award and applicable tax withholdings, the Company shall settle the RSUs for Common Stock as soon as practicable following the earlier to occur of (i) the fifth (5th) business day after the date the reporting person ceases for any reason to be a member of the Company's Board of Directors or (ii) the date of the first annual meeting of stockholders of the Company that occurs following the Grant Date. F2 · derivative.expiration_date: The RSUs vested at issuance on November 11, 2025 (the "Grant Date"). Subject to the terms of the RSU award and applicable tax withholdings, the Company shall settle the RSUs for Common Stock as soon as practicable following the earlier to occur of (i) the fifth (5th) business day after the date the reporting person ceases for any reason to be a member of the Company's Board of Directors or (ii) the date of the first annual meeting of stockholders of the Company that occurs following the Grant Date. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 21:58 UTC |
Martin Patricia A.Director
|
GrantRestricted Stock Units · Derivative | 74,700 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-111446 · tm2531210-8_4seq1.xml · derivative · entry 1 Martin Patricia A. · CIK 0001916764 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,700 Underlying: Common Stock · 74,700 shares Expires not disclosed F1 · derivative.exercise_price: Represents restricted stock units ("RSUs") to be settled on a 1 for 1 basis for shares of Cypherpunk Technologies Inc. ("Company") common stock, par value $0.001 per share ("Common Stock"). The RSUs were awarded pursuant to the Company's 2022 Equity Incentive Plan for no consideration. F2 · derivative.exercise_date: The RSUs vested at issuance on November 11, 2025 (the "Grant Date"). Subject to the terms of the RSU award and applicable tax withholdings, the Company shall settle the RSUs for Common Stock as soon as practicable following the earlier to occur of (i) the fifth (5th) business day after the date the reporting person ceases for any reason to be a member of the Company's Board of Directors or (ii) the date of the first annual meeting of stockholders of the Company that occurs following the Grant Date. F2 · derivative.expiration_date: The RSUs vested at issuance on November 11, 2025 (the "Grant Date"). Subject to the terms of the RSU award and applicable tax withholdings, the Company shall settle the RSUs for Common Stock as soon as practicable following the earlier to occur of (i) the fifth (5th) business day after the date the reporting person ceases for any reason to be a member of the Company's Board of Directors or (ii) the date of the first annual meeting of stockholders of the Company that occurs following the Grant Date. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 21:56 UTC |
Schilsky RichardDirector
|
GrantRestricted Stock Units · Derivative | 74,700 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-111444 · tm2531210-7_4seq1.xml · derivative · entry 1 Schilsky Richard · CIK 0001945662 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,700 Underlying: Common Stock · 74,700 shares Expires not disclosed F1 · derivative.exercise_price: Represents restricted stock units ("RSUs") to be settled on a 1 for 1 basis for shares of Cypherpunk Technologies Inc. ("Company") common stock, par value $0.001 per share ("Common Stock"). The RSUs were awarded pursuant to the Company's 2022 Equity Incentive Plan for no consideration. F2 · derivative.exercise_date: The RSUs vested at issuance on November 11, 2025 (the "Grant Date"). Subject to the terms of the RSU award and applicable tax withholdings, the Company shall settle the RSUs for Common Stock as soon as practicable following the earlier to occur of (i) the fifth (5th) business day after the date the reporting person ceases for any reason to be a member of the Company's Board of Directors or (ii) the date of the first annual meeting of stockholders of the Company that occurs following the Grant Date. F2 · derivative.expiration_date: The RSUs vested at issuance on November 11, 2025 (the "Grant Date"). Subject to the terms of the RSU award and applicable tax withholdings, the Company shall settle the RSUs for Common Stock as soon as practicable following the earlier to occur of (i) the fifth (5th) business day after the date the reporting person ceases for any reason to be a member of the Company's Board of Directors or (ii) the date of the first annual meeting of stockholders of the Company that occurs following the Grant Date. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 21:53 UTC |
Oei Khing DjienDirector
|
GrantRestricted Stock Units · Derivative | 2,411,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-111432 · tm2531210-2_4seq1.xml · derivative · entry 2 Oei Khing Djien · CIK 0002092424 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By CoinXit Ltd Disclosed balance after: 2,411,700 Underlying: Common Stock · 2,411,700 shares Expires not disclosed F1 · derivative.exercise_price: Represents restricted stock units ("RSUs") to be settled on a 1 for 1 basis for shares of Cypherpunk Technologies Inc. ("Company") common stock, par value $0.001 per share ("Common Stock"). F3 · derivative.exercise_price: The RSUs were awarded to CoinXit Ltd ("CoinXit") pursuant to the Consulting Agreement, dated October 6, 2025, by and between the Company and CoinXit, and were issued under the Company's 2022 Equity Incentive Plan. The RSUs will vest at (i) 12/36th on October 8, 2026 and (ii) 1/36th on the eighth (8th) day of each month thereafter (each, a "Vesting Date"), subject to the reporting person's continued service with or to the Company. Subject to the terms of the RSU award and applicable tax withholdings, the Company shall settle vested RSUs for Common Stock on the earliest to occur of (i) the first payroll period on or after the date the reporting person's employment with or service to the Company ceases, (ii) the first payroll period on or after the eighth (8th) day of the calendar month of June following any such Vesting Date applicable to such vested RSU or (iii) the first payroll period on or after the eighth (8th) day of the month of December following any such Vesting Date. F4 · derivative.exercise_price: The reporting person is the director and sole owner of CoinXit, and disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. F3 · derivative.exercise_date: The RSUs were awarded to CoinXit Ltd ("CoinXit") pursuant to the Consulting Agreement, dated October 6, 2025, by and between the Company and CoinXit, and were issued under the Company's 2022 Equity Incentive Plan. The RSUs will vest at (i) 12/36th on October 8, 2026 and (ii) 1/36th on the eighth (8th) day of each month thereafter (each, a "Vesting Date"), subject to the reporting person's continued service with or to the Company. Subject to the terms of the RSU award and applicable tax withholdings, the Company shall settle vested RSUs for Common Stock on the earliest to occur of (i) the first payroll period on or after the date the reporting person's employment with or service to the Company ceases, (ii) the first payroll period on or after the eighth (8th) day of the calendar month of June following any such Vesting Date applicable to such vested RSU or (iii) the first payroll period on or after the eighth (8th) day of the month of December following any such Vesting Date. F4 · derivative.exercise_date: The reporting person is the director and sole owner of CoinXit, and disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. F3 · derivative.expiration_date: The RSUs were awarded to CoinXit Ltd ("CoinXit") pursuant to the Consulting Agreement, dated October 6, 2025, by and between the Company and CoinXit, and were issued under the Company's 2022 Equity Incentive Plan. The RSUs will vest at (i) 12/36th on October 8, 2026 and (ii) 1/36th on the eighth (8th) day of each month thereafter (each, a "Vesting Date"), subject to the reporting person's continued service with or to the Company. Subject to the terms of the RSU award and applicable tax withholdings, the Company shall settle vested RSUs for Common Stock on the earliest to occur of (i) the first payroll period on or after the date the reporting person's employment with or service to the Company ceases, (ii) the first payroll period on or after the eighth (8th) day of the calendar month of June following any such Vesting Date applicable to such vested RSU or (iii) the first payroll period on or after the eighth (8th) day of the month of December following any such Vesting Date. F4 · derivative.expiration_date: The reporting person is the director and sole owner of CoinXit, and disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. F3 · ownership.nature: The RSUs were awarded to CoinXit Ltd ("CoinXit") pursuant to the Consulting Agreement, dated October 6, 2025, by and between the Company and CoinXit, and were issued under the Company's 2022 Equity Incentive Plan. The RSUs will vest at (i) 12/36th on October 8, 2026 and (ii) 1/36th on the eighth (8th) day of each month thereafter (each, a "Vesting Date"), subject to the reporting person's continued service with or to the Company. Subject to the terms of the RSU award and applicable tax withholdings, the Company shall settle vested RSUs for Common Stock on the earliest to occur of (i) the first payroll period on or after the date the reporting person's employment with or service to the Company ceases, (ii) the first payroll period on or after the eighth (8th) day of the calendar month of June following any such Vesting Date applicable to such vested RSU or (iii) the first payroll period on or after the eighth (8th) day of the month of December following any such Vesting Date. F4 · ownership.nature: The reporting person is the director and sole owner of CoinXit, and disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 21:53 UTC |
Oei Khing DjienDirector
|
GrantRestricted Stock Units · Derivative | 74,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-111432 · tm2531210-2_4seq1.xml · derivative · entry 1 Oei Khing Djien · CIK 0002092424 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,700 Underlying: Common Stock · 74,700 shares Expires not disclosed F1 · derivative.exercise_price: Represents restricted stock units ("RSUs") to be settled on a 1 for 1 basis for shares of Cypherpunk Technologies Inc. ("Company") common stock, par value $0.001 per share ("Common Stock"). F2 · derivative.exercise_price: The RSUs were awarded pursuant to the Company's 2022 Equity Incentive Plan for no consideration. The RSUs vested at issuance on November 11, 2025 (the "Grant Date"). Subject to the terms of the RSU award and applicable tax withholdings, the Company shall settle the RSUs for Common Stock as soon as practicable following the earlier to occur of (i) the fifth (5th) business day after the date the reporting person ceases for any reason to be a member of the Company's Board of Directors or (ii) the date of the first annual meeting of stockholders of the Company that occurs following the Grant Date. F2 · derivative.exercise_date: The RSUs were awarded pursuant to the Company's 2022 Equity Incentive Plan for no consideration. The RSUs vested at issuance on November 11, 2025 (the "Grant Date"). Subject to the terms of the RSU award and applicable tax withholdings, the Company shall settle the RSUs for Common Stock as soon as practicable following the earlier to occur of (i) the fifth (5th) business day after the date the reporting person ceases for any reason to be a member of the Company's Board of Directors or (ii) the date of the first annual meeting of stockholders of the Company that occurs following the Grant Date. F2 · derivative.expiration_date: The RSUs were awarded pursuant to the Company's 2022 Equity Incentive Plan for no consideration. The RSUs vested at issuance on November 11, 2025 (the "Grant Date"). Subject to the terms of the RSU award and applicable tax withholdings, the Company shall settle the RSUs for Common Stock as soon as practicable following the earlier to occur of (i) the fifth (5th) business day after the date the reporting person ceases for any reason to be a member of the Company's Board of Directors or (ii) the date of the first annual meeting of stockholders of the Company that occurs following the Grant Date. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 21:54 UTC |
Dietz Thomas JohnDirector
|
GrantRestricted Stock Units · Derivative | 83,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-111433 · tm2531210-3_4seq1.xml · derivative · entry 1 Dietz Thomas John · CIK 0001574218 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,000 Underlying: Common Stock · 83,000 shares Expires not disclosed F1 · derivative.exercise_price: Represents restricted stock units ("RSUs") to be settled on a 1 for 1 basis for shares of Cypherpunk Technologies Inc. ("Company") common stock, par value $0.001 per share ("Common Stock"). The RSUs were awarded pursuant to the Company's 2022 Equity Incentive Plan for no consideration. F2 · derivative.exercise_date: The RSUs vested at issuance on November 11, 2025 (the "Grant Date"). Subject to the terms of the RSU award and applicable tax withholdings, the Company shall settle the RSUs for Common Stock as soon as practicable following the earlier to occur of (i) the fifth (5th) business day after the date the reporting person ceases for any reason to be a member of the Company's Board of Directors or (ii) the date of the first annual meeting of stockholders of the Company that occurs following the Grant Date. F2 · derivative.expiration_date: The RSUs vested at issuance on November 11, 2025 (the "Grant Date"). Subject to the terms of the RSU award and applicable tax withholdings, the Company shall settle the RSUs for Common Stock as soon as practicable following the earlier to occur of (i) the fifth (5th) business day after the date the reporting person ceases for any reason to be a member of the Company's Board of Directors or (ii) the date of the first annual meeting of stockholders of the Company that occurs following the Grant Date. Read SEC document |
| October 08, 2025 Filed Nov 21, 2025 21:15 UTC |
Winklevoss Capital Fund, LLC10% owner
Winklevoss Treasury Investments, LLC10% owner
Winklevoss Tyler Howard10% owner
Winklevoss Cameron Howard10% owner
Winklevoss Capital Management, LLC10% owner
|
GiftWarrant (Right to Buy) · Derivative | 5,616,906 | $0.13 Strike: $0.53 | $702,113.25 |
DisclosureSEC source: 0001231919-25-000542 · form4-11212025_091108.xml · derivative · entry 1 Winklevoss Capital Fund, LLC · CIK 0002085726 · 10% owner Winklevoss Treasury Investments, LLC · CIK 0002092602 · 10% owner Winklevoss Tyler Howard · CIK 0002084694 · 10% owner Winklevoss Cameron Howard · CIK 0002084695 · 10% owner Winklevoss Capital Management, LLC · CIK 0002096657 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Winklevoss Treasury Investments, LLC Disclosed balance after: 57,182,378 Underlying: Common Stock · 5,616,906 shares Expires 2035-10-08 F1 · kind: Represents an assignment of Warrants for no additional consideration. F2 · derivative.exercise_date: The Warrants are exercisable immediately. Notwithstanding the foregoing, the Reporting Persons shall not be entitled to exercise the Warrants to the extent that such exercise would cause the aggregate number of shares of Common Stock beneficially owned by the Reporting Persons, their affiliates and any persons who are members of a Section 13(d) group with the Reporting Persons or their affiliates to exceed 19.99% of the total number of issued and outstanding shares of Common Stock of the Issuer following such exercise. F3 · ownership.nature: Securities are held by Winklevoss Treasury Investments, LLC ("WTI"), which is a wholly owned subsidiary of Winklevoss Capital Fund, LLC ("WCF"). Winklevoss Capital Management, LLC ("WCM") is the manager of WCF and Tyler Winklevoss and Cameron Winklevoss are the co-founders and managers of WCM. Each of the Reporting Persons disclaims beneficial ownership of these securities except to the extent of its or his pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.